US 10426790
Treatment of allergic eye conditions with cyclodextrins
granted A61KA61K31/724A61K9/0048
Quick answer
US patent 10426790 (Treatment of allergic eye conditions with cyclodextrins) held by Aldeyra Therapeutics, Inc. expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/724, A61K9/0048, A61K9/08, A61P